NCT01927224 - Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

September 30, 2014

Conditions

Chagas Disease

Interventions

DRUG

Nifurtimox (BAYa2502) (4 x 30 mg tablet)

120 mg single dose as four 30 mg tablets after a high fat, high calorie meal

DRUG

Nifurtimox (BAYa2502) (slurry of 4 x 30 mg tablets in tap water)

120 mg single dose as aqueous slurry in tap water produced from four 30 mg tablets; ingestion after a high fat, high calorie meal

DRUG

Nifurtimox (BAYa2502) (120 mg tablet)

120 mg single dose as one 120 mg tablet after a high fat, high calorie meal

Trial Locations (1)

Buenos Aires